Closing Bell: Briacell Therapeutics Corp up on Friday (BCT)

Today in trading, Briacell Therapeutics Corp opened at $1.05 and closed at $1.14. prices ranged from $1.05 to $1.14.

The price advanced 8.57% from the previous day's close of $1.05.

Today across North America, the TSX Composite closed -0.16% at 22690.39, the S&P 500 closed -0.78% at 5544.59, the Dow Jones Industrial Average closed -1.29% at 40665.02 and the Nasdaq Composite closed -0.70% at 17871.22.

Briacell Therapeutics Corp traded under BCT on the Toronto Stock Exchange (TSX).

A total of 11,005 shares was traded during the session, with total trades of 36, while having an average volume of 33,336 over the last 5-days.

The TSX overall saw 1,821 price advancers against 3,352 declines and 121 unchanged.

During the prior 52 weeks, BCT.TO has traded as high as $10.29 (August 28,2023) and low as $0.99 (July 18,2024). Moreover, the shares have plummeted -86.57 percent in the last 52 weeks, while this year, they have plummeted -85.38%.

Following today's trading, Briacell Therapeutics Corp has a market capitalization of $19.20 million on a float of 18,285 shares outstanding. Its annual EPS is $-0.37.

Briacell Therapeutics Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Based on 1.00 analysts, Briacell Therapeutics Corp gets an average recommendation of "Strong Buy" according to Zacks. From those 1 analysts, 1 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..